Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.66+0.07 (+4.40%)
Close on Nov 20, 2026Market cap $4.22MP/E –Yield –
Alaunos Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Alaunos Therapeutics's pe ratio was 0.1× on Jan 31, 2025, against 4.3× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 0.1× | −0.0 |
| 2024 | Dec 31, 2024 | 0.2× | −5.5 |
| 2020 | Jan 31, 2020 | 5.7× | −1.1 |
| 2019 | Dec 31, 2019 | 6.8× | – |
See a number that looks wrong?